The global Phosphatidylserine Market is estimated to be valued at US$ 2.27 Bn in 2023 and is expected to exhibit a CAGR of 6.3% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Phosphatidylserine is a type of phospholipid that makes up cell membranes in the brain. It plays an important role in cellular communication and is crucial for many brain functions like memory, concentration and learning. Growing aging population is driving demand for phosphatidylserine as supplements to enhance brain health and prevent age-related cognitive decline. There is high demand from athletes and bodybuilders as phosphatidylserine helps improve muscle recovery and physical performance. It is widely used in functional food and dietary supplements application.
Market key trends:
One of the key trends in the phosphatidylserine market is increased adoption in functional food products. Manufacturers are introducing innovative food and beverage products containing phosphatidylserine to cater to rising demand from health conscious consumers. For instance, sports nutrition brands offer energy bars and drinks enriched with phosphatidylserine targeting fitness enthusiasts. Phosphatidylserine is also popularly used in brain health supplements marketed for elderly population dealing with memory loss or Alzheimer’s. Demand is further expected to rise with growing aging population globally and shift towards preventive healthcare approach against age-related decline.
Threat of new entrants: The phosphatidylserine market requires high R&D investments for product development and branding, which acts as a deterrent for new players.
Bargaining power of buyers: Large buyers can negotiate lower prices, but availability of substitutes is limited due to unique health benefits of phosphatidylserine.
Bargaining power of suppliers: Presence of numerous suppliers worldwide diversifies supply risk.
Threat of new substitutes: Other omega-3 supplements cannot match the brain and cognitive health benefits offered by phosphatidylserine.
Competitive rivalry: The market is moderately concentrated with the top players accounting for over 40% share.
Global Phosphatidylserine Market Size is expected to witness high growth, exhibiting CAGR of 6.3% over the forecast period, due to increasing consumer awareness about cognitive health benefits.
North America dominates the phosphatidylserine market led by the US owing to growing geriatric population and higher health supplement adoption. Asia Pacific is expected to be the fastest growing region on account of rising living standards and health consciousness.
Key players operating in the phosphatidylserine market are Solgar Inc., Nature’s Way Products Llc., Wuhan Demekai biotechnology Co. ltd., Jarrow Formulas Inc, Lipoid Gmbh, Lipogen Products Ltd., Double Wood Llc., Xi€TMan Sino Herb Bio-Technology Co. Ltd., Xian Natural Field Bio- Technique Co. Ltd., N J Chsoyue Pharm Co. Ltd., Swanson Health Products Inc., ECA Healthcare Inc., and IvoVital Gmbh.
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it